Journal
American Journal of Kidney Diseases
Publication Date
3-1-2023
Volume
81
Issue
3
First Page
281
Last Page
293.e1
Document Type
Open Access Publication
DOI
10.1053/j.ajkd.2022.08.012
Rights and Permissions
Alpers DH, Lewis JH, Hunt CM, Freston JW, Torres VE, Li H, Wang W, Hoke ME, Roth SE, Westcott-Baker L, Estilo A. Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials. Am J Kidney Dis. 2023 Mar;81(3):281-293.e1. doi: 10.1053/j.ajkd.2022.08.012. © 2022 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/ licenses/by-nc-nd/4.0/).
Recommended Citation
Alpers, David H; Lewis, James H; Hunt, Christine M; Freston, James W; Torres, Vicente E; Li, Hui; Wang, Wenchyi; Hoke, Molly E; Roth, Sharin E; Westcott-Baker, Lucas; and Estilo, Alvin, "Clinical pattern of tolvaptan-associated liver injury in trial participants with autosomal dominant polycystic kidney disease (ADPKD): An analysis of pivotal clinical trials." American Journal of Kidney Diseases. 81, 3. 281 - 293.e1. (2023).
https://digitalcommons.wustl.edu/oa_4/1370
Additional Links
Supplemental material is available for this article at publisher site.
